PAP
CNTB

Persistent Asset Partners’s Connect Biopharma Holdings CNTB Stock Holding History

Persistent Asset Partners’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$119K Sell
49,873
-874
-2% -$2.12K 0.04% 267
2026
Q1 		$133K Buy
50,747
+23,973
+90% +$62.5K 0.05% 225
2025
Q4 		$75.5K Buy
+26,774
New +$57.1K 0.03% 278

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Persistent Asset Partners's CNTB Position: Q2 2026 in Review

Persistent Asset Partners reduced its Connect Biopharma Holdings (CNTB) stake by 1.7% in Q2 2026, selling an estimated $2.12K and leaving 49,873 shares worth $119K. The position accounts for 0.04% of the portfolio, ranked #267.

Persistent Asset Partners first reported a position in CNTB in Q4 2025 and has held it in 3 quarters since. The position peaked at $133K in Q1 2026. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Persistent Asset Partners held 49,873 shares of Connect Biopharma Holdings worth $119K as of Q2 2026.
  • Persistent Asset Partners sold 874 Connect Biopharma Holdings shares in Q2 2026, an estimated $2.12K.
  • Connect Biopharma Holdings made up 0.04% of Persistent Asset Partners's portfolio in Q2 2026, its #267 holding.
  • Persistent Asset Partners first reported a position in Connect Biopharma Holdings in Q4 2025 and has held it in 3 quarters since.
  • Persistent Asset Partners's Connect Biopharma Holdings position peaked at $133K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.